Max Chat
Company Analysis Alto Neuroscience, Inc.
1. Summary
Advantages
- Price (2.41 $) is less than fair price (11.64 $)
Disadvantages
- Dividends (0%) are below the sector average (1.28%).
- The stock's return over the last year (-79.65%) is lower than the sector average (-44.45%).
- Current debt level 9.54% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-153.99%) is lower than the sector average (ROE=-83.32%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Alto Neuroscience, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -3.6% | -8% | 3.5% |
| 90 days | 13.1% | -49.7% | 10.7% |
| 1 year | -79.6% | -44.4% | 12.7% |
ANRO vs Sector: Alto Neuroscience, Inc. has significantly underperformed the "Healthcare" sector by -35.2% over the past year.
ANRO vs Market: Alto Neuroscience, Inc. has significantly underperformed the market by -92.3% over the past year.
Stable price: ANRO is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ANRO with weekly volatility of -1.53% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (2.41 $) is lower than the fair price (11.64 $).
Price significantly below the fair price: The current price (2.41 $) is 383% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (52.65).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (61.84).
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.93) is lower than that of the sector as a whole (10.86).
P/BV vs Market: The company's P/BV (1.93) is lower than that of the market as a whole (20.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (4.03).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (15.97).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-2.06) is lower than that of the sector as a whole (16.29).
EV/Ebitda vs Market: The company's EV/Ebitda (-2.06) is lower than that of the market as a whole (18.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by 0% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (0%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).
5.4. ROE
ROE vs Sector: The company's ROE (-153.99%) is lower than that of the sector as a whole (-83.32%).
ROE vs Market: The company's ROE (-153.99%) is lower than that of the market as a whole (42.62%).
5.5. ROA
ROA vs Sector: The company's ROA (-46.51%) is lower than that of the sector as a whole (6.38%).
ROA vs Market: The company's ROA (-46.51%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.07%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.15%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.28%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
